Pendred syndrome: Clinical characteristics and molecular basis

Current Opinion in Endocrinology and Diabetes

Volumn 6, Issue 4, 1999, Pages 261-269

  Kopp, Peter ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CHLORIDE ION; IODIDE ION; PERCHLORATE;

ARTICLE; CLINICAL FEATURE; GENE MUTATION; HUMAN; MOLECULAR BIOLOGY; MOLECULAR CLONING; PATHOPHYSIOLOGY; PENDRED SYNDROME; THYROID FOLLICLE CELL;

EID: 0033407055     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199912000-00002     Document Type: Article

References (59)

1. 1 Pendred V: Deaf-mutism and goitre. Lancet 1896, ii:532.
2. 2 Brain WR: Heredity in simple goitre. Q J Med 1927, 20:303-319.
3. 3 Morgans ME, Trotter WR: Association of congenital deafness with goitre: the nature of the thyroid defect. Lancet 1958, 1:607-609.
4. 4 Fraser GR, Morgans ME, Trotter WR: The syndrome of sporadic goitre and congenital deafness. Q J Med 1960, 29:279-295.
5. 5 Medeiros-Neto G, Stanbury JB: Pendred's syndrome: association of congenital deafness with sporadic goiter. In: Inherited disorders of the thyroid system. Edited by Medeiros-Neto G, Stanbury JB. Boca Raton: CRC Press; 1994:81-105.
6. 6 Kopp P: Pendred's syndrome. Identification of the genetic defect a century after its first clinical description. Thyroid 1999, 9:65-69.
7. 7 Nilsson LR, Borgfors N, Gamstorp I, Holst HE, Lidén G: Non-endemic goitre and deafness. Acta Paed 1964, 53:117-131.
8. 8 Fraser GR: Association of congenital deafness with goitre (Pendred's syndrome). Ann Hum Genet 1965, 28:201-249.
9. 9 Reardon W, Coffey R, Phelps PD, Luxon LM, Stephens D, Kendall-Taylor P, Britton KE, Grossman A, Trembath R: Pendred syndrome: 100 years of underascertainement? Q J Med 1997, 90:443-447. In this study, the variable clinical presentation among patients with Pendred syndrome is highlighted by comparing 18 index cases from 18 kindreds with 18 siblings, all with positive linkage to the PDS locus. Although some parameters are not presented in detail, the study indicates that the use of clinical criteria alone will result in underascertainment of Pendred syndrome.
10. 10 Cremers CWRJ, Bolder C, Admiraal RJC, Everett LA, Joosten FBM, Van Hauwe P, Green ED, Otten BJ: Progressive sensorineural hearing loss and a widened vestibular aqueduct in Pendred syndrome. Arch Otolaryngol Head Neck Surg 1998, 124:501-505. The boy presented in this case report developed rapidly progressive sensorineural hearing loss during the first years of life, indicating that the deafness is not congenital in alt patients with PDS mutations. By palpation he did not have a goiter, but his thyroglobulin levels were elevated. Thyroid hormone levels were within the normal range. On computer tomography, he had a displastic cochlea and an enlarged vestibular aqueduct. Molecular analysis of the PDS gene revealed compound heterozygosity for PDS mutations.
11. 11 Hvidberg-Hansen J, Balslev Jørgensen M: The inner ear in Pendred's syndrome. Acta Otolaryngol 1968, 66:129-135.
12. 12 Mondini C: Opuscula Caroli Mundini: Anatomica Surdi Nati Sectio. De Bononiensi Scientarium et Artium Instituto atque Academia Commentarii. Vol Bononia VII: 1791, 419-428.
13. 13 Hartley GJ, Phelps PD: The anatomical section of a boy born deaf (Mondini translation). Am J Otol 1997, 18:288-293.
14. 14 Phelps PD, Coffey RA, Trembath RC, Luxon LM, Grossman AB, Britton KE, Kendall-Taylor P, Graham JM, Cadge BC, Stephens SG, Pembrey ME, Reardon W: Radiological malformations of the ear in Pendred syndrome. Clin Radiol 1998, 53:268-273. Radiologic evaluation of the inner ear documented a large vestibular aqueduct in association with an enlargement of the endolymphatic sac and duct in all patients with Pendred syndrome studied by MRI. The results suggest that malformations of the membranous labyrinth are a more specific diagnostic sign for Pendred syndrome. Together with the studies of Li [36·], Usami [37·], and Abe [55·] that reported an enlarged vestibular aqueduct in all patients with the allelic variants of Pendred syndrome, this study suggests that an enlarged vestibular aqueduct may be a consistent finding in disorders caused by mutations in the PDS gene.
15. 15 Forrest D: Deafness and goiter: molecular genetic considerations. J Clin Endocrinol Metab 1996, 81:2764-2767.
16. 16 Deraemaeker R: Congenital deafness and goiter. Amer J Hum Genet 1956, 8:253-256.
17. 17 Deol MS: An experimental approach to the understanding and treatment of hereditary syndromes with congenital deafness and hypothyroidism. J Med Genet 1973, 10:2768-2772.
18. 18 Meyerhoff WL: Hypothyroidism and the ear: electrophysiological, morphological and chemical considerations. Laryngoscope 1979, 89:1-25.
19. 19 Uziel A, Legrand C, Rabie A: Corrective effects of thyroxine on cochlear abnormalities induced by congenital hypothyroidism in the rat. I. Morphological study. Dev Brain Res 1985, 19:111-122.
20. 20 Uziel A, Marot M, Rabie A: Corrective effects of thyroxine on cochlear abnormalities induced by congenital hypothyroidism in the rat. II. Electrophysiological study. Dev Brain Res 1985, 19:123-127.
21. 21 O'Malley BW, Li D, Turner DS: Hearing loss and cochlear abnormalities in the congenital hypothyroid (hyt/hyt) mouse. Hearing Res 1995, 88:181-189.
22. 22 Forrest D, Erway L, Ng L, Altschuler R, Curran T: Thyroid hormone receptor b is essential for development of auditory function. Nature Genetics 1996, 13:354-357.
23. 23 Kopp P, Kitajima K, Jameson JL: Syndrome of resistance to thyroid hormone: Insights into thyroid hormone action. Proc Soc Exp Biol Med 1996, 211:49-61.
24. 24 Aimeida F, Temporal A, Cavalcanti N, Lins-Neto S, Albuquerque R, Sá T: Pendred's syndrome in an area of endemic goiter in Brazil: genetic and metabolic studies. In: Endemic goiter and cretinism - continuing threats to the world health. Edited by Dunn JT, Medeiros GA. Washington DC: Pan American Health Organization; 1974:167-171.
25. 25 Najjar S: Pendred's syndrome in two families living in endemic goitre area. Br Med J 1963, 2:31-33.
26. 26 Ferraris GM, Zoppetti G, Bidone G, Costa A: Sindrome del Pendred ed endemia di gozzo. Folia Endocrinol 1966, 9:295-312.
27. 27 Gausden E, Armour JA, Coyle B, Coffey R, Hochberg Z, Pembrey M, Britton KE, Grossman A, Reardon W, Trembath R: Thyroid peroxidase: evidence for disease gene exclusion in Pendred's syndrome. Clin Endocrinol 1996, 44:441-446.
28. 28 Studer H, Derwahl M: Mechanisms of non-neoplastic endocrine hyperplasia and hyperfunction: a changing concept. Endocr Rev 1995, 16:411-426.
29. 29 Roberts KD: Thyroid carcinoma in childhood in Great Britain. Arch Dis Childhood 1957, 32:58.
30. 30 Thieme ET: A report of occurrence of deaf-mutism and goiter in four of six siblings of a North American family. Ann Surg 1957, 146:941-948.
31. 31 Elman DS: Familial association of nerve deafness with nodular goiter and thyroid carcinoma. N Engl J Med 1958, 259:219-223.
32. 32 Trotter WR: The association of deafness with thyroid dysfunction. Brit Med Bull 1960, 16:92-98.
33. 33 Coucke P, Van Camp G, Demirhan O, Kabakkaya Y, Balemans W, Van Hauwe P, Van Agtmael T, Smith RJ, Parving A, Bolder CH, Cremers CW, Willems PJ: The gene for Pendred syndrome is located between D7S501 and D7S692 in a 1.7-cM region on chromosome 7q. Genomics 1997, 40:48-54.
34. 34 Delange F, Bastani S, Benmiloud M, De Maeyer E, Isayama M, Koutras D, Muzzo S, Niepomniszcze H, Pandav C, Riccabona G: Definitions of endemic goiter and cretinism, classification of goiter size and severity of endemias, and survey techniques. In: Towards the eradication of endemic goiter, cretinism and iodine deficiency. Edited by Dunn J, Pretell E, Daza C, Viteri F. Washington DC: Pan American Health Organization; 1986:373-376.
35. 35 Kopp P, Karamanoglu Arseven O, Sabacan L, Kotlar T, Dupuis J, Cavaliere H, Santos CLS, Jameson JL, Medeiros-Neto G: Phenocopies for deafness and goiter development in a large inbred kindred with Pendred's syndrome associated with a novel mutation in the PDS gene. J Clin Endocrinol Metab 1999, 84:336-341. In this highly inbred kindred with multiple individuals with deafness and goiter, it was impossible to establish linkage to chromosome 7q31. Mutational analysis of the PDS gene revealed that some individuals have true Pendred syndrome, while others have goiters or deafness caused by distinct environmental or genetic factors. In this study, the problem of phenocopies in linkage studies is illustrated, emphasizing that the diagnosis of Pendred syndrome may be difficult if it has to rely primarily on clinical findings and underscoring the value of molecular diagnosis.
36. 36 Li XC, Everett LA, Lalwani AK, Desmukh D, Friedman TB, Green ED, Wilcox ER: A mutation in PDS causes non-syndromic deafness. Nature Genetics 1998, 18:215-217. In this kindred with nonsyndromic autosomal recessive deafness, linkage could be established to chromosome 7q31. Goiters were absent and enlarged vestibular aqueducts were found in the 3 affected individuals that could be evaluated by computer tomography. Mutational analysis of the PDS gene revealed homozygosity for 2 substitutions (G97S, 1490L) in affected individuals. This supports the notion that the nonsyndromic deafness found to be linked to the DFNB4 locus on chromosome 7q31 is an allelic form of the syndromic hearing loss in Pendred syndrome.
37. 37 Usami S, Abe S, Weston MD, Shinkawa H, Van Camp G, Kimberling WJ: Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations. Hum Genet 1999, 104:188-192. In 6 families with nonsyndromic hearing impairment associated with enlarged vestibular aqueducts and positive linkage to the PDS locus [55·], analysis of the PDS gene resulted in the detection of mutations. Three families were found to be homozygous, and 3 families were compound heterozygous. None of the patients fulfilled the criteria for Pendred syndrome. The study defines hearing loss associated with nonsyndromic familial enlarged vestibular aqueduct as an allelic variant of Pendred syndrome.
38. 38 Sheffield VC, Kraiem Z, Beck JC, Nishimura D, Stone EM, Salameh M, Sadeh O, Glaser B: Pendred syndrome maps to chromosome 7q21-34 and is caused by an intrinsic defect in thyroid iodine organification. Nature Genet 1996, 12:424-426.
39. 39 Coyle B, Coffrey R, Armour JAL, Gausden E, Hochberg Z, Grossmann A, Britton K, Pembrey M, Reardon W, Trembath R: Pendred syndrome (goitre and sensorineural hearing loss) maps to chromosome 7 in the region containing the nonsyndromic deafness gene DFNB4. Nature Genet 1996, 12:421-423.
40. 40 Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED: Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nature Genetics 1997, 17:411-422. The report on the cloning of the PDS gene is of particular interest given the detailed comments on the methodologic approach using, in part, a novel strategy. In addition, the study contains a comparison of the PDS gene to several sulfate transporters, the only published data on PDS expression, and the first mutations in the PDS gene.
41. 41 Coyle B, Reardon W, Herbrick JA, Tsui LC, Gausden E, Lee J, Coffey R, Grueters A, Grossman A, Phelps PD, Luxon L, Kendall-Taylor P, Scherer SW, Trembath RC: Molecular analysis of the PDS gene in Pendred syndrome (sensorineural hearing loss and goitre). Hum Mol Genet 1998, 7:1105-1112. Besides a characterization of the PDS locus, mutatlonal analysis in familial and sporadic patients with Pendred syndrome is provided in this article, illustrating the significant diversity of mutations in the PDS gene.
42. 42 Schweinfest CW, Henderson KW, Suster S, Kondoh N, Papas TS: Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomas. Proc Natl Acad Sci USA 1993, 90:4166-4170.
43. 43 Silberg DG, Wang W, Moseley RH, Traber PG: The down regulated in adenoma (dra) gene encodes an intestine-specific membrane sulfate transport protein. J Biol Chem 1995, 270:11897-11902.
44. 44 Hastbacka J, De la Chapelle A, Mahtani M, Clines G, Reeve-Daly M, Daly M, Hamilton B, Kusumi K, Trivedi B, Weaver A, Coloma A, Lovett M, Buckler A, Kaitila I, Lander ES: The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell 1994, 78:1073-1087.
45. 45 Bissig M, Hagenbuch B, Stieger B, Koller T, Meier PJ: Functional expression cloning of the canalicular sulfate transport system of rat hepatocytes. J Biol Chem 1994, 269:3017-3021.
46. 46 Hoglund P, Haila S, Socha J, Tomaszewski L, Saarialho-Kere U, Karjalainen-Lindsberg ML, Airola K, Holmberg C, De la Chapelle A, Kere J: Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhea. Nat Genet 1996, 14:316-319.
47. 47 Moseley RH, Hoglund P, Wu GD, Silberg DG, Haila S, De la Chapelle A, Holmberg C, Kere J: Downregulated in adenoma gene encodes a chloride transporter defective in congenital chloride diarrhea. Am J Physiol 1999, 276:G185-G192. In this article, evidence is provided that DRA, the closest relative of pendrin, is not only a transporter of sulfate but also of chloride. This finding was not unexpected because DRA mutations cause congenital chloride diarrhea [46].
48. 48 Superti-Furga A, Haestbacka J, Wilcox WR, Cohn DH, Van der Harten HJ, Rossi A, Blau N, Rimoin DL, Steinmann B, Lander ES, Gitzelmann R: Achondrogenesis type 2 is caused by mutations in the diastrophic dysplasia sulphate transporter gene. Nat Genet 1996, 12:100-102.
49. 49 Rossi A, Van der Harten HJ, Beemer FA, Kleijer WA, Gitzelmann R, Sleinmann B, Superti-Furga B: Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia. Hum Genet 1996, 98:657-661.
50. 50 Scott DA, Wang R, Kreman TM, Sheffield VC, Karniski LP: The Pendred syndrome gene encodes a chloride-iodide transport protein. Nature Genet 1999, 21:440-443. Using a Xenopus oocyte system and Sf9 cells, Scott et al, demonstrate that pendrin mediates iodide and chloride uptake and that it is not a sulfate transporter. In contrast to the sodium-iodide symporter, pendrin does not require the presence of sodium. Pendrin-mediated anion-transport can be partially inhibited by nonspecific transport inhibitors.
51. 51 Dai G, Levy O, Carrasco N: Cloning and characterization of the thyroid iodide transporter. Nature 1996, 379:458-460.
52. 52 Smanik P, Liu Q, Furminger T, Ryu K, Xing S, Mazzaferri E, Jhiang S: Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun 1996, 226:339-345.
53. 53 Van Hauwe P, Everett LA, Coucke P, Scott DA, Kraft ML, Ris-Stalpers C, Bolder C, Otten B, De Vipder JJM, Dietrich NL, Ramesh A, Srisaitapathy SCR, Parving A, Cremers CWRJ, Willems PJ, Smith RJH, Green ED, Van Camp G: Two frequent missense mutations in Pendred syndrome. Hum Mol Genet 1998, 7:1099-1104. Mutational analysis of 14 families of different ethnic origin, 5 of them consanguineous, revealed 14 mutations in the PDS gene, 2 of which were frequently recurrent. Two families were homozygous for L236P, and 5 harbored this mutation in 1 allele. Two families were homozygous for T416P and 4 were compound heterozygous. Given the large diversity of PDS mutations (Table 1), the high prevalence of these particular mutations is presumably not of further diagnostic relevance as proposed by the authors.
54. 54 Baldwin CT, Weiss S, Farrer LA, De Stefano AL, Adair R, Franklyn B, Kidd KK, Korostishevsky M, Bonne-Tamir B: Linkage of congenital, recessive deafness (DFNB4) to chromosome 7q31 and evidence for genetic heterogeneity in the Middle Eastern Druze population. Hum Mol Genet 1995, 4:1637-1642.
55. 55 Abe S, Usami S, Hoover DM, Cohn M, Shinkawa H, Kimberling WJ: Fluctuating sensorineural hearing loss associated with enlarged vestibular aqueduct maps to 7q31, the region containing the Pendred gene. Am J Ned Genet 1999, 82:322-328. In 10 familial cases with nonsyndromic hearing impairment associated with enlarged vestibular aqueducts, linkage was established to the PDS locus. In a subsequent study, Usami et al. reported on the mutational analysis of 6 of these families and demonstrated that they harbor mutations in the PDS gene [·37].
56. 56 Liu XZ, Walsh J, Mburu P, Kendrick-Jones J, Cope MJTV, Steel KP, Brown SDM: Mutations in the myosin VIIA gene cause non-syndromic recessive deafness. Nat Genet 1997, 16:188-190.
57. 57 Liu X, Walsh J, Tamagawa Y, Kitamura K, Nishizawa M, Steel KP, Brown SDM: Autosomal dominant non-syndromic deafness caused by a mutation in the myosin VIIA gene. Nat Genet 1997, 17:268-269.
58. 58 Weil D, Blanchard S, Kaplan J, Guilford P, Gibson F, Walsh J, Mburu P, Varela A, Levilliers J, Weston MD, Kelley PM, Kimberling WJ, Wagenaar M, Levi-Acobas F, Larget-Piet D, Munnich A, Steel KP, Brown SDM, Petit C: Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 1995, 374:60-61.
59. 59 Liu XZ, Hope C, Walsh J, Newton V, Ke XM, Liang CY, Xu LR, Zhou JM, Trump D, Steel KP, Bundey S, Brown SD: Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome. Am J Hum Genet 1998, 63:909-912.